Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors

Journal of Experimental Medicine

Volumn 193, Issue 8, 2001, Pages 935-942

  Zhong, Guangming ^a   Fan, Peiyi ^a   Ji, Hezhao ^b   Dong, Feng ^a   Huang, Yanqing ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Antigen presentation; Chlamydial enzyme; Degradation; Immune evasion; Transcription factors

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; PROTEINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UPSTREAM STIMULATION FACTOR 1;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CHLAMYDIA; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; SEQUENCE HOMOLOGY; T LYMPHOCYTE;

CELL-FREE SYSTEM; CHLAMYDIA TRACHOMATIS; CHROMATOGRAPHY, ION EXCHANGE; CYTOSOL; DNA-BINDING PROTEINS; ENDOPEPTIDASES; HELA CELLS; HUMANS; KINETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; TRANSCRIPTION FACTORS; UPSTREAM STIMULATORY FACTORS;

EID: 0035896736     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.193.8.935     Document Type: Article

References (21)

1. Persistent chlamydiae: From cell culture to a paradigm for chlamydial pathogenesis
2. Persistent "silent" Chlamydia trachomatis female genital tract infections
3. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis
4. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells
5. Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1
6. Inhibition of apoptosis in chlamydia-infected cells: Blockade of mitochondrial cytochrome c release and caspase activation
7. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein
8. Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP)
9. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis
10. Comparative genomes of Chlamydia pneumoniae and C. trachomatis
11. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39
12. Origins and functions of the chlamydial inclusion
13. Lipid metabolism in Chlamydia trachomatis-infected cells: Directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion
14. Molecular mimicry and Chlamydia trachomatis infection of eukaryotic cell
15. Chlamydia: Old ideas crushed, new mysteries bared
16. Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis
17. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
18. The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate
19. Viral subversion of the immune system
20. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome
21. Dislocation of type 1 membrane proteins from the ER to the cytosol is sensitive to changes in redox potential